403 related articles for article (PubMed ID: 28408002)
1. Economic Burden of Attention-Deficit/Hyperactivity Disorder among Pediatric Patients in the United States.
Gupte-Singh K; Singh RR; Lawson KA
Value Health; 2017 Apr; 20(4):602-609. PubMed ID: 28408002
[TBL] [Abstract][Full Text] [Related]
2. Medical Expenditures Associated with Attention-Deficit/Hyperactivity Disorder Among Adults in the United States by Age, 2015-2019.
Witrick B; Zhang D; Su D; Li Y; McCall WV; Hendricks B; Shi L
J Gen Intern Med; 2023 Jul; 38(9):2082-2090. PubMed ID: 36781580
[TBL] [Abstract][Full Text] [Related]
3. Parent-Reported Health Consequences and Relationship to Expenditures in Children with ADHD.
deJong NA; Williams CS; Thomas KC
Matern Child Health J; 2016 Apr; 20(4):915-24. PubMed ID: 26754346
[TBL] [Abstract][Full Text] [Related]
4. Attention-deficit/hyperactivity disorder: increased costs for patients and their families.
Swensen AR; Birnbaum HG; Secnik K; Marynchenko M; Greenberg P; Claxton A
J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1415-23. PubMed ID: 14627876
[TBL] [Abstract][Full Text] [Related]
5. Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey.
Chan E; Zhan C; Homer CJ
Arch Pediatr Adolesc Med; 2002 May; 156(5):504-11. PubMed ID: 11980558
[TBL] [Abstract][Full Text] [Related]
6. Children and adolescents with attention deficit-hyperactivity disorder: 1. Prevalence and cost of care.
Burd L; Klug MG; Coumbe MJ; Kerbeshian J
J Child Neurol; 2003 Aug; 18(8):555-61. PubMed ID: 13677583
[TBL] [Abstract][Full Text] [Related]
7. Economic Impact of Headache and Psychiatric Comorbidities on Healthcare Expenditures Among Children in the United States: A Retrospective Cross-Sectional Study.
Law EF; Palermo TM; Zhou C; Groenewald CB
Headache; 2019 Oct; 59(9):1504-1515. PubMed ID: 31520418
[TBL] [Abstract][Full Text] [Related]
8. Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: a descriptive analysis.
Quintero J; Ramos-Quiroga JA; Sebastián JS; Montañés F; Fernández-Jaén A; Martínez-Raga J; Giral MG; Graell M; Mardomingo MJ; Soutullo C; Eiris J; Téllez M; Pamias M; Correas J; Sabaté J; García-Orti L; Alda JA
BMC Psychiatry; 2018 Feb; 18(1):40. PubMed ID: 29422022
[TBL] [Abstract][Full Text] [Related]
9. Welfare consequences for people diagnosed with attention deficit hyperactivity disorder (ADHD): A matched nationwide study in Denmark.
Jennum P; Hastrup LH; Ibsen R; Kjellberg J; Simonsen E
Eur Neuropsychopharmacol; 2020 Aug; 37():29-38. PubMed ID: 32682821
[TBL] [Abstract][Full Text] [Related]
10. Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States.
Doshi JA; Hodgkins P; Kahle J; Sikirica V; Cangelosi MJ; Setyawan J; Erder MH; Neumann PJ
J Am Acad Child Adolesc Psychiatry; 2012 Oct; 51(10):990-1002.e2. PubMed ID: 23021476
[TBL] [Abstract][Full Text] [Related]
11. Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/hyperactivity disorder.
Schein J; Cloutier M; Gauthier-Loiselle M; Bungay R; Chen K; Chan D; Childress A
J Manag Care Spec Pharm; 2024 Jun; 30(6):588-598. PubMed ID: 38824634
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder.
Secnik K; Swensen A; Lage MJ
Pharmacoeconomics; 2005; 23(1):93-102. PubMed ID: 15693731
[TBL] [Abstract][Full Text] [Related]
13. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder.
Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
Pediatrics; 2001 Jul; 108(1):71-8. PubMed ID: 11433056
[TBL] [Abstract][Full Text] [Related]
14. Direct medical and indirect absenteeism costs among working adult ADHD patients in the United States.
Shah CH; Onukwugha E
Expert Rev Pharmacoecon Outcomes Res; 2022 Sep; 22(6):1013-1020. PubMed ID: 35502641
[TBL] [Abstract][Full Text] [Related]
15. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.
Birnbaum HG; Kessler RC; Lowe SW; Secnik K; Greenberg PE; Leong SA; Swensen AR
Curr Med Res Opin; 2005 Feb; 21(2):195-206. PubMed ID: 15801990
[TBL] [Abstract][Full Text] [Related]
16. Direct medical costs of ADHD and its comorbid conditions on basis of a claims data analysis.
Libutzki B; Ludwig S; May M; Jacobsen RH; Reif A; Hartman CA
Eur Psychiatry; 2019 May; 58():38-44. PubMed ID: 30802682
[TBL] [Abstract][Full Text] [Related]
17. Impact of mental health comorbidities on health care utilization and expenditure in a large US managed care adult population with ADHD.
Kawatkar AA; Knight TK; Moss RA; Sikirica V; Chu LH; Hodgkins P; Haim Erder M; Nichol MB
Value Health; 2014 Sep; 17(6):661-8. PubMed ID: 25236989
[TBL] [Abstract][Full Text] [Related]
18. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.
Pelham WE; Foster EM; Robb JA
Ambul Pediatr; 2007; 7(1 Suppl):121-31. PubMed ID: 17261491
[TBL] [Abstract][Full Text] [Related]
19. Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD).
Hakkaart-van Roijen L; Zwirs BW; Bouwmans C; Tan SS; Schulpen TW; Vlasveld L; Buitelaar JK
Eur Child Adolesc Psychiatry; 2007 Aug; 16(5):316-26. PubMed ID: 17483870
[TBL] [Abstract][Full Text] [Related]
20. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013.
Albert M; Rui P; Ashman JJ
NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
